Managing Myeloma
- 2010-06-25 - Celgene Gets Japanese Approval For Lenalidomide Cancer Treatment
- 2010-06-23 - Second National Myeloma (Bone Marrow Cancer) Awareness Week was Launched on Friday in the Mansion House, Dublin, Ireland
- 2010-06-21 - Walker Co. Sheriff Back on Job After Bout with Cancer
- 2010-06-16 - Genetic Variations Influence Patient Response to Treatment for Multiple Myeloma: Presented at EHA
- 2010-06-16 - Zoledronic acid boosts survival in multiple myeloma patients
- 2010-06-16 - Lenalidomide-Based Triple Therapy Prolongs Progression-Free Survival in Elders With Multiple Myeloma: Presented at EHA
- 2010-06-15 - Immunomedics Doses First Patient in Phase I/II Study of Milatuzumab-Doxorubicin Conjugate for Multiple Myeloma Therapy
- 2010-06-15 - Lenalinomide Maintenance in Multiple Myeloma: New Standard of Care?-Medscape Medical News
- 2010-06-15 - Celgene reports updated results from Phase III multiple myeloma study
- 2010-06-15 - EMEA Approves Update to Bortezomib Label to Include Survival Benefit in Previously Untreated Patients with Multiple Myeloma
- 2010-06-14 - Follow-Up Bortezomib/Thalidomide Therapy Increases Progression-Free Survival in Elderly Patients With Multiple Myeloma: Presented at EHA
- 2010-06-10 - Pat’s Place: Having Multiple Myeloma Isn’t Simple — It’s Hard!
- 2010-06-09 - Human Genome Sciences says cancer drug fails study:Mapatumumab
- 2010-06-09 - Cancer wins may be bigger than they seem
- 2010-06-08 - PharmaMar Initiates a Phase III Registration Trial with Plitidepsin [Aplidin(R)] in Multiple Myeloma Patients